BIAFW
bioAffinity Technologies, Inc.
Set alert
0.22 USD 0.00 0.00%
0.218 Day range 0.2448
0.218 52-week range 0.218
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.47
- Prev close
- 0.218
- Mkt cap
- 5.37M
- Vol
- 25
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.218
- High
- 0.2448
- Forward P/E
- 0.00
- Beta
- 3.12
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.65
- EPS (TTM)
- 0.00
- Beta
- 3.12
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -119.41%
- Revenue (TTM)
- 7.32M
- Revenue growth
- 12047.40%
- Free cash flow
- -4.29M
- Total cash
- 801.31K
- Total debt
- 1.38M
- Return on equity
- -151.52%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- bioaffinitytech.com
News
- bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Shares Shorted: Short Interest Up 334.6% in September
- BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant
- bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 10.8% – Here’s What Happened
- bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
Your note
Sign in to keep a note on BIAFW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 15.88% | 204,082 | 68.65K | Sep 29, 2024 |
| Clear Street LLC | 4.27% | 54,933 | 18.48K | Sep 29, 2024 |
| Citadel Advisors Llc | 3.05% | 39,180 | 13.18K | Sep 29, 2024 |
| UBS Group AG | 0.04% | 467 | 157 | Sep 29, 2024 |